Search research articles
Contact Us
Filters
Showing results (571-580 of 640) with videos related to
Page
of 64
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
January 28, 2014
D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial
A T Cohen, T E Spiro, A C Spyropoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2005
Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR
Michael Mitas, Jonas S Almeida, Kaidi Mikhitarian, et al.
Journal of the American Heart Association
|
February 15, 2021
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients
Gary E Raskob, Alex C Spyropoulos, Alexander T Cohen, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
May 14, 2024
Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors
Mark Goldin, Kolton Smith, Ioannis Koulas, et al.
Pilot and Feasibility Studies
|
February 2, 2022
Moving on trial: protocol for a pilot randomised controlled trial of models of housing and support to reduce risks of COVID-19 infection and homelessness
Elizabeth Randell, Bethan Pell, Gwenllian Moody, et al.
The New England Journal of Medicine
|
August 28, 2018
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
Alex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
European Journal of Immunology
|
November 8, 2024
Characterization of the Molecular Signature of Human Monocytes in Aging and Myelodysplastic Neoplasms
Christina Maria Rimpa, Maria Grigoriou, Athanasios Tasis, et al.
Journal of the American College of Cardiology
|
June 27, 2020
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
Alex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
October 28, 2022
Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis
Sahrish Shah, Meritxell Urtecho, Mohammed Firwana, et al.
Thrombosis and Haemostasis
|
February 5, 2016
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications
Gary E Raskob, Alex C Spyropoulos, Julie Zrubek, et al.
Page
of 64
Search research articles
Search
Showing results (571-580 of 640) with videos related to
Sort By:
Page
of 64
Journal of Thrombosis and Haemostasis : JTH
|
January 28, 2014
D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial
A T Cohen, T E Spiro, A C Spyropoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2005
Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR
Michael Mitas, Jonas S Almeida, Kaidi Mikhitarian, et al.
Journal of the American Heart Association
|
February 15, 2021
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients
Gary E Raskob, Alex C Spyropoulos, Alexander T Cohen, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
May 14, 2024
Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors
Mark Goldin, Kolton Smith, Ioannis Koulas, et al.
Pilot and Feasibility Studies
|
February 2, 2022
Moving on trial: protocol for a pilot randomised controlled trial of models of housing and support to reduce risks of COVID-19 infection and homelessness
Elizabeth Randell, Bethan Pell, Gwenllian Moody, et al.
The New England Journal of Medicine
|
August 28, 2018
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
Alex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
European Journal of Immunology
|
November 8, 2024
Characterization of the Molecular Signature of Human Monocytes in Aging and Myelodysplastic Neoplasms
Christina Maria Rimpa, Maria Grigoriou, Athanasios Tasis, et al.
Journal of the American College of Cardiology
|
June 27, 2020
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
Alex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
October 28, 2022
Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis
Sahrish Shah, Meritxell Urtecho, Mohammed Firwana, et al.
Thrombosis and Haemostasis
|
February 5, 2016
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications
Gary E Raskob, Alex C Spyropoulos, Julie Zrubek, et al.
Page
of 64